Emerald Investment Advisers LLC Invests $12.51 Million in UnitedHealth Group Incorporated $UNH

Emerald Investment Advisers LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 30,090 shares of the healthcare conglomerate’s stock, valued at approximately $12,506,000. UnitedHealth Group makes up approximately 0.8% of Emerald Investment Advisers LLC’s portfolio, making the stock its 22nd largest position.

Other hedge funds and other institutional investors also recently modified their holdings of the company. LFG Wealth Partners LLC increased its holdings in UnitedHealth Group by 3.3% in the second quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock valued at $355,000 after buying an additional 27 shares during the last quarter. Synergy Financial Group LTD grew its position in shares of UnitedHealth Group by 3.1% in the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock worth $369,000 after acquiring an additional 27 shares in the last quarter. Ares Financial Consulting LLC increased its holdings in shares of UnitedHealth Group by 7.2% in the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock valued at $174,000 after acquiring an additional 28 shares during the last quarter. Rockland Trust Co. lifted its stake in UnitedHealth Group by 1.1% during the second quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock worth $1,076,000 after purchasing an additional 29 shares during the last quarter. Finally, Matrix Trust Co boosted its holdings in UnitedHealth Group by 24.8% in the second quarter. Matrix Trust Co now owns 146 shares of the healthcare conglomerate’s stock worth $61,000 after purchasing an additional 29 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. Cantor Fitzgerald restated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, June 11th. Robert W. Baird upgraded shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and increased their price objective for the stock from $287.00 to $453.00 in a research note on Thursday, July 16th. Bank of America restated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 20th. Piper Sandler set a $477.00 price target on UnitedHealth Group in a report on Thursday, July 16th. Finally, BMO Capital Markets set a $512.00 target price on UnitedHealth Group in a research report on Tuesday, July 21st. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $455.92.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 500 shares of the firm’s stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $410.00, for a total transaction of $205,000.00. Following the completion of the transaction, the chief executive officer owned 16,497 shares in the company, valued at approximately $6,763,770. This trade represents a 2.94% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.19% of the company’s stock.

UnitedHealth Group Stock Up 2.3%

UNH stock opened at $398.89 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $358.04 billion, a price-to-earnings ratio of 25.67, a price-to-earnings-growth ratio of 1.35 and a beta of 0.62. The firm’s 50-day moving average is $413.74 and its two-hundred day moving average is $357.26.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. During the same period in the prior year, the firm posted $4.08 earnings per share. The firm’s revenue for the quarter was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 19.81 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be given a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group’s payout ratio is 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.